Abrdn PLC Abb Vie Inc. Transaction History

Abrdn PLC

$51.7 Billion
Q4 2024

A detailed history of Abrdn PLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Abrdn PLC holds 1,761,831 shares of ABBV stock, worth $346 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

1,761,831

Previous 1,986,664 11.32%

Holding current value

$346 Million

Previous $392 Million 20.2%

% of portfolio

0.61%

Previous 0.74%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	SELL	$164.99 - $203.87 $37.1 Million - $45.8 Million	-224,833 Reduced 11.32%	1,761,831 $313 Million
Q3 2024 Oct 24, 2024	SELL	$163.84 - $199.33 $10.4 Million - $12.6 Million	-63,210 Reduced 3.08%	1,986,664 $392 Million
Q2 2024 Aug 09, 2024	SELL	$154.79 - $180.76 $31.7 Million - $37 Million	-204,819 Reduced 9.08%	2,049,874 $352 Million
Q1 2024 May 08, 2024	SELL	$159.82 - $182.1 $3.05 Million - $3.48 Million	-19,109 Reduced 0.84%	2,254,693 $411 Million
Q4 2023 Jan 31, 2024	BUY	$137.6 - $154.97 $114 Million - $129 Million	830,187 Added 57.51%	2,273,802 $352 Million
Q3 2023 Nov 06, 2023	SELL	$133.59 - $154.65 $18.4 Million - $21.3 Million	-137,483 Reduced 8.7%	1,443,615 $215 Million
Q2 2023 Jun 20, 2024	SELL	$132.51 - $164.9 $153 Million - $190 Million	-1,154,778 Reduced 42.21%	1,581,098 $213 Million
Q2 2023 Aug 04, 2023	SELL	$132.51 - $164.9 $153 Million - $190 Million	-1,154,778 Reduced 42.21%	1,581,098 $213 Million
Q1 2023 Jun 20, 2024	SELL	$144.61 - $166.54 $14.6 Million - $16.9 Million	-101,306 Reduced 3.57%	2,735,876 $436 Million
Q1 2023 Apr 28, 2023	SELL	$144.61 - $166.54 $14.6 Million - $16.9 Million	-101,306 Reduced 3.57%	2,735,876 $436 Million
Q4 2022 Jun 20, 2024	BUY	$138.31 - $165.87 $80.6 Million - $96.6 Million	582,489 Added 25.83%	2,837,182 $459 Million
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $4.19 Million - $5.03 Million	-30,313 Reduced 1.06%	2,837,182 $459 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $21.5 Million - $24.7 Million	-160,380 Reduced 5.3%	2,867,495 $385 Million
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $80 Million - $102 Million	-581,525 Reduced 16.11%	3,027,875 $463 Million
Q1 2022 May 04, 2022	SELL	$131.98 - $163.75 $164 Million - $204 Million	-1,245,427 Reduced 25.65%	3,609,400 $594 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $19.1 Million - $24.1 Million	177,490 Added 3.79%	4,854,827 $657 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $3.7 Million - $4.2 Million	-34,805 Reduced 0.74%	4,677,337 $512 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $15.2 Million - $16.9 Million	144,264 Added 3.16%	4,712,142 $531 Million
Q1 2021 May 06, 2021	BUY	$102.3 - $112.62 $26.2 Million - $28.8 Million	256,073 Added 5.94%	4,567,878 $494 Million
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $14.9 Million - $20.2 Million	185,649 Added 4.5%	4,311,805 $462 Million
Q3 2020 Oct 21, 2020	SELL	$85.91 - $100.83 $14.1 Million - $16.6 Million	-164,310 Reduced 3.83%	4,126,156 $361 Million
Q2 2020 Aug 10, 2020	BUY	$73.37 - $98.18 $26.2 Million - $35.1 Million	357,374 Added 9.09%	4,290,466 $421 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $109 Million - $166 Million	1,693,650 Added 75.63%	3,933,092 $300 Million
Q4 2019 Feb 18, 2020	BUY	$72.13 - $90.25 $3.85 Million - $4.82 Million	53,407 Added 2.44%	2,239,442 $198 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $77.2 Million - $92.8 Million	1,225,068 Added 127.48%	2,186,035 $166 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $4.41 Million - $5.63 Million	67,080 Added 7.5%	960,967 $69.9 Million
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $9.29 Million - $10.9 Million	120,383 Added 15.56%	893,887 $72 Million
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $3.93 Million - $4.84 Million	-50,442 Reduced 6.12%	773,504 $69.5 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $19.7 Million - $21.9 Million	-221,533 Reduced 21.19%	823,946 $77.9 Million
Q2 2018 Aug 09, 2018	SELL	$89.78 - $106.23 $155 Million - $184 Million	-1,731,287 Reduced 62.35%	1,045,479 $96.9 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $7.64 Million - $10.2 Million	83,073 Added 3.08%	2,776,766 $263 Million
Q4 2017 Feb 12, 2018	BUY	$89.56 - $98.21 $62.4 Million - $68.4 Million	696,254 Added 34.86%	2,693,693 $261 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $140 Million - $178 Million	1,997,439	1,997,439 $177 Million

Others Institutions Holding ABBV

# of Institutions

4,082

Shares Held

1.28B

Call Options Held

16.7M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $347B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account